NEFROLOGIE IEPER (0724.846.158) — Belgian company profile — Rovalta
ACTIVEBCE 0724.846.158
NI
NEFROLOGIE IEPER
Equity
19,4 k €
solvency 0,7 %
Total balance sheet
2,8 M €
filing 23/07/2025
Key figures
Financial data
2024
2023
2022
2021
Gross margin
3,1 k €
-18.4%
3,8 k €
+93.2%
2,0 k €
+38.3%
1,4 k €
EBITDA
2,0 k €
-26.4%
2,7 k €
+175.8%
990,0 €
+122.2%
445,6 €
Operating profit
1,0 k €
-40.8%
1,8 k €
+252.5%
500,8 €
+12.4%
445,6 €
Equity
19,4 k €
0.0%
19,4 k €
0.0%
19,4 k €
0.0%
19,4 k €
Total assets
2,8 M €
+7.3%
2,6 M €
+0.1%
2,6 M €
+3.7%
2,5 M €
Cash
63,0 k €
+895.5%
6,3 k €
-88.6%
55,7 k €
+14.8%
48,5 k €
Debts
2,8 M €
+7.3%
2,6 M €
+0.1%
2,6 M €
+3.7%
2,5 M €
Competition
Similar companies
At this address
Other companies at this address
Health score
Solv.4.0
Liq.4.0
Prof.4.0
Z-Score
3.1
NSSO & social debts
9,8 %
Recommended credit limit
€ 1.30M
Maximum recommended credit amount, based on solvency, liquidity and profitability.
Available with a free account
✦ Verdict · Analyst summary
Private limited company with a balanced profile. Cash position rising (+895.5%).
Recommendation
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Financial overview
Financial year 2024
Assets
2,8 M €
+7.3%
Equity
19,4 k €
0.0%
Gross margin
3,1 k €
-18.4%
Cash
63,0 k €
+895.5%
Debts
2,8 M €
+7.3%
Questions
Frequently asked questions
What does NEFROLOGIE IEPER do?
NEFROLOGIE IEPER is a Private limited company incorporated in 2019. Its main activity is: Specialist medical practice activities. Its registered office is in Ieper.